Libbensduerûndersyk: wat wy yn 2026 witte
August 7, 2026 · Frisian News
Longevity research attracts $5 billion yearly in private funding, yet the longest-living people on Earth follow timeless practices: regular movement, real food, and strong social bonds.
FryskLibbensduerûndersyk krijt jierliks 5 miljard dollar partikuliere ynvestearring. It measte giet nei biotechbedriuwen dy't avansearre pillen neistrewe. Underwilens dogge minsken dy't it langst libje wat ienfâldiger: se ite minder bewurke iten, bewege elke dei, en hâlde sterke freonskippen.
De wittenskip is earlik genôch. Genetika bepaalt sawat 30 prosint fan dyn libbensduer. De rest hinget ôf fan wat do dochst. Dy fining is tsien jier net feroare. Dochs hellet it gjin koppen. In nij medisyn dat mûzen 20 prosint langer libje lit, stiet op foarsiden en lûkt risikokapitaal oan. Immen dy't ophâldt mei op de bank sitten? Dat ferhaal ferkeapet gjin abonneminten.
Tech-miljardêrs en farmabedriuwen neame 'sellulêre herprogrammearring' en 'senolytyske medisinen' de takomst fan ferâldering. Harren prikkel is dúdlik. In wurkjend anty-âlderdomsmiddel soe de grutste merk fan skiednis wêze. Net elkenien kin saaie gewoanten folgje. Mar elkenien soe in pil keapje kinne. Dy ekonomyske werklikheid bepaalt hokker ûndersyk finansierd wurdt en hokker ferhalen ferteld wurde.
It wurklike bewiis is tinner as koppen suggerearje. Guon bistefersiken litte belofte sjen. Minsklike fersiken binne lyts, fan koarte doer, en faak finansierd troch bedriuwen dy't harren eigen produkten teste. De minsken dy't it langst libje dy't wy kenne, libje yn fiif regio's wrâldwiid. Nimmen naam djoere supplementen. Se wurken, ieten benammen plantaardich iten, dronken deistich wyn of kofje, en bleaune ticht by famylje.
Libbensduerûndersikers sille de moanne bliuwe neijeien. It jild is goed. De ferbiningen binne goed. Mar as do lang libje wolst, is it advys net feroare sûnt dyn beppe's tiid. Beweeg. Yt echt iten. Hâld freonen ticht. Doch dat, en do ferslachst 80 prosint fan de minsken dy't op de folgjende wûnderpil wachtsje.
Longevity research gets $5 billion a year in private investment. Most flows to biotech firms pursuing fancy pills. Meanwhile, people who live longest worldwide do something simpler: they eat less processed food, move every day, and maintain strong friendships.
The science is honest enough. Genetics accounts for roughly 30 percent of lifespan. The rest depends on what you do. That finding has not changed in a decade. Yet it makes no headlines. A new drug extending mouse lifespan by 20 percent reaches front pages and attracts venture capital. A person who stops sitting on the couch? That story sells no subscriptions.
Tech billionaires and pharmaceutical companies promote 'cellular reprogramming' and 'senolytic drugs' as aging's future. Their incentive is obvious. An effective anti-aging drug would be history's largest market. Not everyone can pursue boring habits. But everyone might buy a pill. That economic reality shapes which research gets funded and which stories get told.
The real evidence is thinner than headlines suggest. Some animal studies show promise. Human trials are small, short-term, and often funded by companies testing their own products. The longest-lived people we know live in five regions globally. None took expensive supplements. They worked, ate mostly plants, drank wine or coffee daily, and stayed close to family.
Longevity researchers will keep chasing the moon. The money is good. The headlines are good. But if you want to live long, the advice has not shifted since your grandmother's time. Move. Eat real food. Keep friends near. Do that, and you beat 80 percent of people waiting for the next miracle pill.
Published August 7, 2026 · Frisian News · Ljouwert, Fryslân